HLX07 alone or combined with serplulimab, cisplatin and 5‐fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study

Authors

Institutions

Publication Details

Journal
Cancer Communications
Published
2024-10-24
DOI
https://doi.org/10.1002/cac2.12621
Citations
4
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HLX07 alone or combined with serplulimab, cisplatin and 5‐fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study

Zhenbo Tan, Mudan Yang, Xuhui Hu, Yuan Yuan et al.
4 citations
Cancer Communications
Lymphoma Diagnosis and Treatment
1.70
article

HLX07 alone or combined with serplulimab, cisplatin and 5‐fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study

Zhenbo Tan, Mudan Yang, Xuhui Hu, Yuan Yuan, Ying Wang, Ning Li, Bo Liu, Yanfeng Wang, Jing Huang, Haoyu Yu, Tao Wu, Jiayan Chen, Jin Zhou, Jun Zhu, Yanrong Zhu, Zhenyang Liu, Wu Zhuang, Yun Liu, Qingyu Wang, Lin Wang
article en
4 citations

Abstract

No abstract available for this paper.
Cancer CommunicationsVol. 44(12)
Hebei Medical University (CN), Academy of Medical Sciences (GB), Central South University (CN), University of Electronic Science and Technology of China (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), Zhengzhou University (CN), Fudan University Shanghai Cancer Center (CN), Shandong Tumor Hospital (CN), Shanxi Provincial Cancer Hospital (CN), National Supercomputing Center in Shenzhen (CN), Xingtai People's Hospital (CN), Hunan Cancer Hospital (CN), Sichuan Cancer Hospital (CN), National Clinical Research (US), Xuzhou Central Hospital (CN), Cancer Hospital of Chinese Academy of Medical Sciences (CN), Henan Cancer Hospital (CN), Fujian Provincial Cancer Hospital (CN), Viva Biotech (China) (CN), Shenzhen Blood Center (CN), Anyang Tumor Hospital (CN), Shandong First Medical University (CN)
Good health and well-being
Openalex Percentile: Top 15%
Lymphoma Diagnosis and Treatment
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.